company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16240000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16240000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,912000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,171000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,795000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1159000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-15521000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-15521000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2331000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,14546000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,12215000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,12215000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,37000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-64000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-64000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-9000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q1,2014-01-01,2014-03-31,2015-05-12 07:15:58+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3379000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,46831000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,46831000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,931000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,136000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,670000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,44191000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,92759000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,92759000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1621000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,19000000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,17379000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,17379000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1167000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,831000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-37000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-473000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-473000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,44000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q2,2014-04-01,2014-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,109709000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-39535000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-39535000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1487000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,102000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8269000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1382000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31059000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31059000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1590000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,3410000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,3410000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-1027000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,94000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1034000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1034000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-90000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q3,2014-07-01,2014-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-28773000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-50560000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-50560000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1140000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,249000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8954000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,16452000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-23765000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-23765000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-2576000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-144727000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,10000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7000000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-140293000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-140293000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-941000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,20772000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,155933000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,175663000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,175663000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-39000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,11566000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2014.0,Q4,2014-10-01,2014-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,377000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46367000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46367000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1388000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,768000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6446000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-4425000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-42190000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-42190000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-448000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,0.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5000000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,4552000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,4552000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,721000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,0.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,620000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,620000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-68000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q1,2015-01-01,2015-03-31,2016-05-09 16:25:14+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-37086000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,57055000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,57055000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1408000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,770000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7042000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,34772000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,101047000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,101047000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-541000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,2035000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,1494000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,1494000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,4887000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4787000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4787000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,839000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q2,2015-04-01,2015-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,108167000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45098000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45098000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1422000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,754000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6755000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-1958000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-38125000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-38125000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-679000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-16683000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17154000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-208000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-208000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2915000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2814000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2814000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-833000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q3,2015-07-01,2015-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-36352000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-51369000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-51369000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1461000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,705000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,7333000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2567000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-39303000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-39303000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-309000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-25053000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,2000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,13654000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-11706000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-11706000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6469000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2243000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,4125000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,4125000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-46860000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2015.0,Q4,2015-10-01,2015-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,335000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-27841000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-27841000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1502000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,695000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,6720000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1666000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17258000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17258000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-898000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-19000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,0.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,5976000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,5059000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,5059000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1213000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-1261000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-149000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-149000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-17000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q1,2016-01-01,2016-03-31,2017-05-09 16:11:56+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-12365000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24154000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24154000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1513000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,689000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8312000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,11873000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1767000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1767000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-87000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-26000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,8698000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,8585000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,8585000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,1641000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-451000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,1089000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,1089000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-35000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q3,2016-07-01,2016-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,7872000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30390000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30390000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1520000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,649000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8312000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,1364000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18545000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18545000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-146000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-8969000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-9115000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-9115000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3744000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-498000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3145000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3145000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,24000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-24501000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2016.0,Q4,2016-10-01,2016-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,295000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30610000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30610000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1525000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,613000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,8376000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-7039000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27135000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27135000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-636000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-30000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,5000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,24069000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,23408000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,23408000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,3099000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2424000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,574000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,574000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-31000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:13:17+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-3184000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31912000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31912000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1547000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,451000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9504000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,652000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-19758000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-19758000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-976000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17932000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,16920000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,16920000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-386000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,9145000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,113801000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,122460000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,122460000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,31000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q2,2017-04-01,2017-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,119679000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24459000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24459000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1510000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,439000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,9591000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-5515000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-18434000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-18434000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3380000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-36000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,12957000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,9541000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,9541000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-44000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,16312000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,353858000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,370025000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,370025000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q3,2017-07-01,2017-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,361096000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33894000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33894000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1517000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,341000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10953000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,19897000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-1186000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-1186000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3508000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-67000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,23572000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,19997000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,19997000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,repurchaseofcommonequity,Repurchase of Common Equity,+,debit,usd,-514000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6354000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2326000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3413000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3413000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,51000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,22285000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2017.0,Q4,2017-10-01,2017-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,255000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41396000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41396000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1519000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,277000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,10727000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3090000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-31963000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-31963000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1837000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-44000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,17180000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,15299000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,15299000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8959000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-6813000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2045000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2045000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q1,2018-01-01,2018-03-31,2019-05-09 16:21:37+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-14651000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-23421000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-23421000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1564000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,186000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13426000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-26719000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-34964000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-34964000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1868000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-54000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,184000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,16377000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,14639000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,14639000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,8384000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3192000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,5092000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,5092000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q2,2018-04-01,2018-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-15204000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-42556000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-42556000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1610000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,121000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14309000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,34764000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,8248000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,8248000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1147000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-110058000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,22000000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-89205000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-89205000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofdebt,Issuance of Debt,+,debit,usd,49000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7255000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-3283000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,3920000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,3920000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q3,2018-07-01,2018-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-77081000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,20953000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,20953000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,1869000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,-626000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,13724000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-53385000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-17465000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-17465000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-3168000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-466724000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,7036000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-462856000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-462856000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-107000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5249000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-2324000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,2818000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,2818000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-8000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-477464000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2018.0,Q4,2018-10-01,2018-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,218000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-78348000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-78348000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2868000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2451000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,16756000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-3213000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-59486000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-59486000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-459000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-38000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,56506000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,56009000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,56009000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-2915000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,7004000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5279000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-1190000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-1190000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,-39000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q1,2020-01-01,2020-03-31,2020-05-07 16:12:03+00:00,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-4706000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,148940000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,148940000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2655000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,232000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17247000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,-115760000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,53314000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,53314000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1747000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-105473000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,43494000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-63726000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-63726000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,2713000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,6333000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-8636000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,410000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,410000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,netchangeincash,effectofexchangeratechanges,Effect of Exchange Rate Changes,+,debit,usd,39000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q2,2019-04-01,2019-06-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-9965000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-49439000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-49439000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,3192000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,1683000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,14774000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,2307000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-27483000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-27483000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1811000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-50421000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,205000000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,152768000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,152768000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-100000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,2373000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5509000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-3236000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-3236000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q3,2019-07-01,2019-09-30,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,122005000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,netincome,Consolidated Net Income / (Loss),+,credit,usd,-98123000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-98123000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,depreciationexpense,Depreciation Expense,+,debit,usd,2432000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,amortizationexpense,Amortization Expense,+,debit,usd,2274000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,noncashadjustmentstonetincome,Non-Cash Adjustments To Reconcile Net Income,+,debit,usd,17360000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingoperatingactivities,increasedecreaseinoperatingcapital,"Changes in Operating Assets and Liabilities, net",+,debit,usd,31007000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromoperatingactivities,netcashfromcontinuingoperatingactivities,Net Cash From Continuing Operating Activities,+,debit,usd,-45050000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromoperatingactivities,Net Cash From Operating Activities,+,debit,usd,-45050000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofplantpropertyandequipment,"Purchase of Property, Plant & Equipment",+,debit,usd,-1745000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,purchaseofinvestments,Purchase of Investments,+,debit,usd,-255367000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofplantpropertyandequipment,"Sale of Property, Plant & Equipment",+,debit,usd,7000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuinginvestingactivities,saleofinvestments,Sale and/or Maturity of Investments,+,debit,usd,232072000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfrominvestingactivities,netcashfromcontinuinginvestingactivities,Net Cash From Continuing Investing Activities,+,debit,usd,-25033000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfrominvestingactivities,Net Cash From Investing Activities,+,debit,usd,-25033000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,repaymentofdebt,Repayment of Debt,+,debit,usd,-101000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,issuanceofcommonequity,Issuance of Common Equity,+,debit,usd,5068000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromcontinuingfinancingactivities,otherfinancingactivitiesnet,"Other Financing Activities, net",+,debit,usd,-5251000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netcashfromfinancingactivities,netcashfromcontinuingfinancingactivities,Net Cash From Continuing Financing Activities,+,debit,usd,-284000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,netchangeincash,netcashfromfinancingactivities,Net Cash From Financing Activities,+,debit,usd,-284000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,,netchangeincash,Net Change in Cash & Equivalents,=,debit,usd,-70326000.0
FibroGen Inc,FGEN,549300Q914ULWWY95822,0000921299,2019.0,Q4,2019-10-01,2019-12-31,,,cashinterestpaid,Cash Interest Paid,=,,usd,174000.0
